{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:24:15Z","timestamp":1764084255298,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["Actually (UK), not (US). Details in manuscript"],"award-info":[{"award-number":["Actually (UK), not (US). Details in manuscript"]}],"id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12981-016-0104-0","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T07:56:04Z","timestamp":1460620564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evolution of changes in cognitive function after the initiation of antiretroviral therapy"],"prefix":"10.1186","volume":"13","author":[{"given":"Borja","family":"Mora-Peris","sequence":"first","affiliation":[]},{"given":"Elizabeth","family":"Stevens","sequence":"additional","affiliation":[]},{"given":"Francesca","family":"Ferretti","sequence":"additional","affiliation":[]},{"given":"Jonathan","family":"Underwood","sequence":"additional","affiliation":[]},{"given":"Stephen","family":"Taylor","sequence":"additional","affiliation":[]},{"given":"Alan","family":"Winston","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"104_CR1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1212\/WNL.41.6.778","volume":"41","author":"Report of a Working Group of the American Academy of Neurology AIDS Task Force","year":"1991","unstructured":"Report of a Working Group of the American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology. 1991;41:778\u201385.","journal-title":"Neurology"},{"key":"104_CR2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.56.2.257","volume":"56","author":"N Sacktor","year":"2001","unstructured":"Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, et al. HIV- associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990\u20131998. Neurology. 2001;56:257\u201360.","journal-title":"Neurology"},{"key":"104_CR3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/cid\/ciq041","volume":"52","author":"F-X Lescure","year":"2011","unstructured":"Lescure F-X, Omland LH, Engsig FN, Roed C, Gerstoft J, Pialoux G, et al. Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study. Clin Infect Dis. 2011;52:235\u201343.","journal-title":"Clin Infect Dis"},{"key":"104_CR4","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/01.WNL.0000038347.48137.67","volume":"59","author":"CH Hinkin","year":"2002","unstructured":"Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59:1944\u201350.","journal-title":"Neurology"},{"key":"104_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1355617711000968","volume":"17","author":"T Al-Khindi","year":"2011","unstructured":"Al-Khindi T, Zakzanis KK, van Gorp WG. Does antiretroviral therapy improve HIV-associated cognitive impairment? A quantitative review of the literature. J Int Neuropsychol Soc. 2011;17:1\u201314.","journal-title":"J Int Neuropsychol Soc"},{"key":"104_CR6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.0b013e3181ab2b3b","volume":"73","author":"LA Cysique","year":"2009","unstructured":"Cysique LA, Vaida F, Letendre S, et al. Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology. 2009;73:342\u20138.","journal-title":"Neurology"},{"key":"104_CR7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1468-1293.2011.00962.x","volume":"13","author":"A Winston","year":"2012","unstructured":"Winston A, Puls R, Kerr SJ, et al. Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study. HIV Med. 2012;13:245\u201351.","journal-title":"HIV Med"},{"issue":"11","key":"104_CR8","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(14)70137-1","volume":"13","author":"S Nightingale","year":"2014","unstructured":"Nightingale S, Winston a, Letendre S, et al. Controversies in HIV-associated neurocognitive disorders. Lancet Neurol. 2014;13(11):1139\u201351.","journal-title":"Lancet Neurol"},{"issue":"3","key":"104_CR9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11904-014-0221-0","volume":"11","author":"P Chan","year":"2014","unstructured":"Chan P, Brew BJ. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment. Curr HIV\/AIDS Rep. 2014;11(3):317\u201324.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"104_CR10","volume-title":"Neuropsychological Assessment","author":"M Lezac","year":"1995","unstructured":"Lezac M. Neuropsychological Assessment. 3rd ed ed. New York: Oxford University Press; 1995.","edition":"3"},{"key":"104_CR11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.acn.2005.07.011","volume":"21","author":"LA Cysique","year":"2006","unstructured":"Cysique LA, Maruff P, Darby D, Brew BJ. The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol. 2006;21:185\u201394.","journal-title":"Arch Clin Neuropsychol"},{"issue":"2","key":"104_CR12","doi-asserted-by":"crossref","first-page":"e0118608","DOI":"10.1371\/journal.pone.0118608","volume":"10","author":"A Winston","year":"2015","unstructured":"Winston A, Puls R, Kerr SJ, Duncombe C, Li P, Gill JM, Ramautarsing R, Taylor-Robinson SD, Emery S, Cooper DA. ALTAIR Study Group. Differences in the direction of change of cerebral function parameters are evident over 3\u00a0years in HIV-infected individuals electively commencing initial cART. PLoS ONE. 2015;10(2):e0118608.","journal-title":"PLoS ONE"},{"issue":"7","key":"104_CR13","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1076\/jcen.24.7.912.8391","volume":"24","author":"DJ Hardy","year":"2002","unstructured":"Hardy DJ, Hinkin CH. Reaction time performance in adults with HIV\/AIDS. J Clin Exp Neuropsychol. 2002;24(7):912\u201329.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"8","key":"104_CR14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1468-1293.2008.00636.x","volume":"9","author":"BG Gazzard","year":"2008","unstructured":"Gazzard BG, Anderson J, Babiker A, Boffito M, Brook G, Brough G, Churchill D, Cromarty B, Das S, Fisher M, Freedman A, Geretti AM, Johnson M, Khoo S, Leen C, Nair D, Peters B, Phillips A, Pillay D, Pozniak A, Walsh J, Wilkins E, Williams I, Williams M, Youle M. BHIVA treatment guidelines writing group. British HIV association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med. 2008;9(8):563\u2013608.","journal-title":"HIV Med"},{"issue":"9","key":"104_CR15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"JD Lundgren","year":"2015","unstructured":"INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, F\u00e4tkenheuer G, Llibre JM, Molina JM, Munderi P, Schechter M, Wood R, Klingman KL, Collins S, Lane HC, Phillips AN, Neaton JD. Initiation of antiretroviral therapy in early asymptomatic hiv infection. N Engl J Med. 2015;373(9):795\u2013807.","journal-title":"N Engl J Med"},{"key":"104_CR16","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf . Accessed 14 Oct 2015."},{"key":"104_CR17","doi-asserted-by":"crossref","unstructured":"Churchill D, Waters L, Ahmed N, Angus B, Boffito M, Bower M, Dunn D, Edwards S, Emerson C, Fidler S, Fisher M, Horne R, Khoo S, Leen C, Mackie N, Marshall N, Monteiro F, Nelson M, Orkin C, Palfreeman A, Pett S, Phillips A, Post F, Pozniak A, Reeves I, Sabin C, Trevelion R, Walsh J, Wilkins E, Williams I, Winston A British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015. http:\/\/www.bhiva.org\/documents\/Guidelines\/Treatment\/2015\/2015-treatment-guidelines.pdf . Accessed 19 Oct 2015.","DOI":"10.1111\/hiv.12426"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-016-0104-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T19:00:36Z","timestamp":1718478036000},"score":1,"resource":{"primary":{"URL":"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-016-0104-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,14]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["104"],"URL":"https:\/\/doi.org\/10.1186\/s12981-016-0104-0","relation":{},"ISSN":["1742-6405"],"issn-type":[{"type":"electronic","value":"1742-6405"}],"subject":[],"published":{"date-parts":[[2016,4,14]]},"article-number":"20"}}